Institute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany.
Institute for Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany.
Int J Mol Sci. 2018 Oct 2;19(10):3007. doi: 10.3390/ijms19103007.
Tetraspanins are suggested to regulate the composition of cell membrane components and control intracellular transport, which leaves them vulnerable to utilization by pathogens such as human papillomaviruses (HPV) and cytomegaloviruses (HCMV) to facilitate host cell entry and subsequent infection. In this study, by means of cellular depletion, the cluster of differentiation (CD) tetraspanins CD9, CD63, and CD151 were found to reduce HPV16 infection in HeLa cells by 50 to 80%. Moreover, we tested recombinant proteins or peptides of specific tetraspanin domains on their effect on the most oncogenic HPV type, HPV16, and HCMV. We found that the C-terminal tails of CD63 and CD151 significantly inhibited infections of both HPV16 and HCMV. Although CD9 was newly identified as a key cellular factor for HPV16 infection, the recombinant CD9 C-terminal peptide had no effect on infection. Based on the determined half-maximal inhibitory concentration (IC), we classified CD63 and CD151 C-terminal peptides as moderate to potent inhibitors of HPV16 infection in HeLa and HaCaT cells, and in EA.hy926, HFF (human foreskin fibroblast) cells, and HEC-LTT (human endothelial cell-large T antigen and telomerase) cells for HCMV, respectively. These results indicate that HPV16 and HCMV share similar cellular requirements for their entry into host cells and reveal the necessity of the cytoplasmic CD151 and CD63 C-termini in virus infections. Furthermore, this highlights the suitability of these peptides for functional investigation of tetraspanin domains and as inhibitors of pathogen infections.
四跨膜蛋白被认为可以调节细胞膜成分的组成并控制细胞内运输,这使得它们容易被人类乳头瘤病毒 (HPV) 和巨细胞病毒 (HCMV) 等病原体利用,以促进宿主细胞进入和随后的感染。在这项研究中,通过细胞耗竭的方法,发现分化群 (CD) 四跨膜蛋白 CD9、CD63 和 CD151 将 HeLa 细胞中的 HPV16 感染减少了 50%至 80%。此外,我们测试了特定四跨膜蛋白结构域的重组蛋白或肽对最致癌 HPV 类型 HPV16 和 HCMV 的影响。我们发现 CD63 和 CD151 的 C 端尾部显著抑制了 HPV16 和 HCMV 的感染。尽管 CD9 被新确定为 HPV16 感染的关键细胞因子,但重组 CD9 C 端肽对感染没有影响。根据确定的半最大抑制浓度 (IC),我们将 CD63 和 CD151 C 端肽分类为中度至强效 HPV16 感染抑制剂,分别在 HeLa 和 HaCaT 细胞以及 EA.hy926、HFF(人包皮成纤维细胞)细胞和 HEC-LTT(人内皮细胞大 T 抗原和端粒酶)细胞中用于 HCMV。这些结果表明 HPV16 和 HCMV 进入宿主细胞的过程存在相似的细胞需求,并揭示了细胞质 CD151 和 CD63 C 端在病毒感染中的必要性。此外,这突出了这些肽作为四跨膜蛋白结构域功能研究和病原体感染抑制剂的适用性。